Henoch-Schönlein purpura associated with Strongyloides stercoralis infection
Abstract
Introduction. Henoch-Schönlein purpura (HSP) is a small blood vessel vasculitis, which usually manifests during childhood. The exact cause of the disease is unknown. Case report. We reported a 14-year-old girl who had been admitted to our clinic due to the appearance of red macules on her extremities and face, vomiting, and pain in the abdomen and joints. The patient was initially diagnosed with Henoch-Schönlein purpura. At the end of the fourth week of illness, larvae of Strongyloides stercoralis were detected in stool samples. The patient was therefore treated with mebendazole, after which all symptoms permanently withdrew. About a month later laboratory examinations were repeated demonstrating increasing signs of renal damage. Kidney biopsy was performed, showing mesangioproliferative glomerulonephritis with crescents and IgA and C3 positive staining in the mesangium. Upon reviewing the clinical presentation, biochemically demonstrated progressive renal damage and biopsy results, the patient was diagnosed with HSP nephritis. Conclusion. The time course of the disease and present knowledge concerning the pathogenic mechanisms of HSP suggest that Strongyloides stercoralis infection could have caused HSP in the presented patient, which was complicated by nephritis.
References
Niaudet P, Habib R. Schönlein-Henoch purpura nephritis: pronostic factors and therapy. Ann Med Interne (Paris) 1994; 145(8): 577−80.
Saulsbury FT. Clinical update: Henoch-Schönlein purpura. Lan-cet 2007; 369(9566): 976−8.
Chen K, Carlson AJ. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol 2008; 9(2): 71−92.
Ebert EC. Gastrointestinal manifestations of Henoch-Schonlein Purpura. Dig Dis Sci 2008; 53(8): 2011−9.
Tizard EJ, Hamilton-Ayres MJ. Henoch Schonlein purpura. Arch Dis Child Educ Pract Ed 2008; 93(1): 1−8.
Koskimies O, Rapola J, Savilahti E, Vilska J. Renal involvement in Schönlein-Henoch purpura. Acta Pediatr Scand 1974; 63(3): 357−63.
Stewart M, Savage JM, Bell B, McCord B. Long term renal prog-nosis of Henoch-Schönlein purpura in an unselected child-hood population. Eur J Pediatr 1988; 147(2): 113−5.
Butani L, Morgenstern BZ. Long-term Outcome in Children Af-ter Henoch-Schonlein Purpura Nephritis. Clin Pediatr 2007; 46(6): 505−11.
Ruperto N, Ozen S, Pistorio A, Dolezalova P, Brogan P, Cabral DA, et al. EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation. Ann Rheum Dis 2010; 69(5): 790−7.
Ronkainen J, Koskimies O, Ala-Houhala M, Antikainen M, Merenmies J, Rajantie J, et al. Early prednisone therapy in Henoch-Schönlein purpura: a randomized, double-blind, placebo-controlled trial. J Pediatr 2006; 149(2): 241−7.
Jauhola O, Ronkainen J, Koskimies O, Ala-Houhala M, Arikoski P, Hölttä T, et al. Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: a 6-month prospective study. Arch Dis Child 2010; 95(11): 871−6.
Bogdanović R. Henoch-Schönlein purpura nephritis in children: risk factors, prevention and treatment. Acta Paediatr 2009; 98(12): 1882−9.
Rigante D, Castellazzi L, Bosco A, Esposito S. Is there a crossroad between infections, genetics, and Henoch-Schönlein purpura. Autoimmun Rev 2013; 12(10): 1016−21.
Hernando-Harder AC, Booken N, Goerdt S, Singer MV, Harder H. Helicobacter pylori infection and dermatologic diseases. Eur J Dermatol 2009; 19(5): 431−44.
Ergür AT, Cetinkaya O, Onarlioğlu B. Paediatric patients with Henoch-Schönlein purpura followed up at Cumhuriyet Uni-versity, Sivas, Turkey during 1993-1996: role of parasitosis in the aetiology of Henoch-Schönlein purpura. J Trop Pediatr 1999; 45(3): 177−8.
Kim YO, Choi YS, Won YH, Kim YD, Woo YJ, Back HJ, et al. Intestinal amebiasis with Henoch-Schönlein purpura. Pediatr Int 2010; 52(4): 667−9.
Thapa R, Mallick D, Biswas B, Ghosh A, Chakrabartty S, Dhar S. Henoch-schonlein purpura triggered by falciparum cerebral malaria. Clin Pediatr (Phila) 2010; 49(7): 699−701.
Besbas N, Saatci U, Ruacan S, Ozen S, Sungur A, Bakkaloglu A, et al. The role of cytokines in Henoch Schonlein purpura. Scand J Rheumatol 1997; 26(6): 456−60.
Niemir ZI, Stein H, Noronha IL, Krüger C, Andrassy K, Ritz E, et al. PDGF and TGF-beta contribute to the natural course of human IgA glomerulonephritis. Kidney Int 1995; 48(5): 1530−41.
Szer IS. Henoch-Schönlein purpura. Curr Opin Rheumatol 1994; 6(1): 25−31.
Yilmaz D, Kavakli K, Ozkayin N. The elevated markers of hy-percoagulability in children with Henoch-Schönlein purpura. Pediatr Hematol Oncol 2005; 22(1): 41−8.
He X, Yu C, Zhao P, Ding Y, Liang X, Zhao Y, et al. The genet-ics of Henoch-Schönlein purpura: a systematic review and me-ta-analysis. Rheumatol Int 2013; 33(6): 1387−95.
Saulsbury FT. Henoch-Schönlein purpura. Curr Opin Rheu-matol 2001; 13(1): 35−40.
van den Wall BA, Daha MR, Evers-Schouten J, van Es LA. Serum IgA and the production of IgA by peripheral blood and bone marrow lymphocytes in patients with primary IgA nephropa-thy: evidence for the bone marrow as the source of mesangial IgA. Am J Kidney Dis 1988; 12(5): 410−4.
Buck KS, Smith AC, Molyneux K, El-Barbary H, Feehally J, Barratt J. B-cell O-galactosyltransferase activity, and expression of O-glycosylation genes in bone marrow in IgA nephropathy. Kid-ney Int 2008; 73(10): 1128−36.
Smith AC, Molyneux K, Feehally J, Barratt J. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J Am Soc Nephrol 2006; 17(12): 3520−8.
Béné MC, Faure GC. Mesangial IgA in IgA nephropathy arises from the mucosa. Am J Kidney 1988; 12(5): 406−9.
Allen AC, Willis FR, Beattie TJ, Feehally J. Abnormal IgA glyco-sylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 1998; 13(4): 930−4.
Lau KK, Wyatt RJ, Moldoveanu Z, Tomana M, Julian BA, Hogg RJ, et al. Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schönlein purpura. Pediatr Nephrol 2007; 22(12): 2067−72.
Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, et al. Ab-errantly glycosylated IgA1 in IgA nephropathy patients is rec-ognized by IgG antibodies with restricted heterogeneity. J Clin Invest 2009; 119(6): 1668−77.
Suzuki H, Moldoveanu Z, Hall S, Brown R, Vu HL, Novak L, et al. IgA1-secreting cell lines from patients with IgA nephropa-thy produce aberrantly glycosylated IgA1. J Clin Invest 2008; 118(2): 629−39.
Raska M, Moldoveanu Z, Suzuki H, Brown R, Kulhavy R, Andrasi J, et al. Identification and characterization of CMP-NeuAc:GalNAc-IgA1 alpha2,6-sialyltransferase in IgA1-producing cells. J Mol Biol 2007; 369(1): 69−78.
Mattu TS, Pleass RJ, Willis AC, Kilian M, Wormald MR, Lellouch AC, et al. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions. J Biol Chem 1998; 273(4): 2260−72.
Novak J, Tomana M, Kilian M, Coward L, Kulhavy R, Barnes S, et al. Heterogeneity of O-glycosylation in the hinge region of human IgA1. Mol Immunol 2000; 37(17): 1047−56.
Smith AC, Feehally J. New insights into the pathogenesis of IgA nephropathy. Pathogenesis of IgA nephropathy. Springer Semin Immunopathol 2003; 24(4): 477−93.
Amoli MM, Thomson W, Hajeer AH, Calviño MC, Garcia-Porrua C, Ollier WE, et al. HLA-B35 association with nephritis in Henoch-Schönlein purpura. J Rheumatol 2002; 29(5): 948−9.
Hsieh YP, Wen YK, Chen ML. Minimal change nephrotic syn-drome in association with strongyloidiasis. Clin Nephrol 2006; 66(6): 459−63.
Bangs MJ, Sirait S, Maguire JD. Strongyloidiasis with gastric mu-cosal invasion presenting with acute interstitial nephritis. Southeast Asian J Trop Med Public Health 2006; 37(4): 641−7.
Haas M. Jennette JC, Olson JL, Schwartz MM, Silva FG. IgA nephropathy and Henoch-Schönlein purpura. 6th ed. Philadel-phia: Lippincott Williams & Wilkins; 2007. p. 423−86.
Shu KH, Lu YS, Chen CH, Sheu SS, Chan LP, Lian JD. Serum immunoglobulin E in primary IgA nephropathy. Clin Nephrol 1995; 44(2): 86−90.
Niedermaier G, Briner V. Henoch-Schönlein syndrome induced by carbidopa/levodopa. Lancet 1997; 349(9058): 1071−2.
Michail S, Vaiopoulos G, Nakopoulou L, Revenas C, Aroni K, Karam P, et al. Henoch-Schoenlein purpura and acute interstitial nephritis after intravenous vancomycin administration in a patient with a staphylococcal infection. Scand J Rheumatol 1998; 27(3): 233−5.
Saulsbury FT. Henoch-Schönlein purpura in children. Report of 100 patients and review of the literature. Medicine 1999; 78(6): 395−409.
Dawod ST, Akl KF. Henoch-Schöenlein syndrome in Qatar: the effects of steroid therapy and paucity of renal involvement. Ann Trop Paediatr 1990; 10(3): 279−84.
Reinehr T, Bürk G, Andler W. Does steroid treatment of ab-dominal pain prevent renal involvement in Henoch-Schönlein purpura. J Pediatr Gastroenterol Nutr 2000; 31(3): 323−4.
Rosenblum ND, Winter HS. Steroid effects on the course of ab-dominal pain in children with Henoch-Schonlein purpura. Pe-diatrics 1987; 79(6): 1018−21.
Fardet L, Généreau T, Poirot J, Guidet B, Kettaneh A, Cabane J. Se-vere strongyloidiasis in corticosteroid-treated patients: case se-ries and literature review. J Infect 2007; 54(1): 18−27.
Arsić-Arsenijević V, Dzamić A, Dzamić Z, Milobratović D, Tomić D. Fatal Strongyloides stercoralis infection in a young woman with lupus glomerulonephritis. J Nephrol 2005; 18(6): 787−90.
Miyazaki M, Tamura M, Kabashima N, Serino R, Shibata T, Miya-moto T, et al. Minimal change nephrotic syndrome in a patient with strongyloidiasis. Clin Exp Nephrol 2010; 14(4): 367−71.
Siddiqui AA, Berk SL. Diagnosis of Strongyloides stercoralis infection. Clin Infect Dis 2001; 33(7): 1040−7.
Boram LH, Keller KF, Justus DE, Collins JP. Strongyloidiasis in immunosuppressed patients. Am J Clin Pathol 1981; 76(6): 778−81.
Kimmelstiel F, Lange M. Fatal systemic strongyloidiasis following corticosteroid therapy. N Y State J Med 1984; 84(8): 399−401.
Pasqualini L, Crotti D, Scarponi A, Vaudo G, Mannarino E. Stron-gyloides stercoralis infection in a patient with Crohn's disease. Eur J Clin Microbiol Infect Dis 1997; 16(5): 401−3.
Yee YK, Lam CS, Yung CY, Que TL, Kwan TH, Au TC, et al. . Strongyloidiasis as a possible cause of nephrotic syndrome. Am J Kidney Dis 1999; 33(6): e4.
Wong TY, Szeto CC, Lai FF, Mak CK, Li PK. Nephrotic syn-drome in strongyloidiasis: remission after eradication with an-thelmintic agents. Nephron 1998; 79(3): 333−6.